|
|
||||||||
J Thorac Cardiovasc Surg 1996;112:1064-1072
© 1996 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Supported by National Institutes of Health Grant HL-45024, a Basic Research Grant from Pfizer Inc., a South Carolina American Heart Association Grant, and a Grant-in-Aid from the American Heart Association. F.G.S. is an Established Investigator of the American Heart Association.
Received for publication Jan. 22, 1996 Revisions requested March 13, 1996; revisions received April 26, 1996 Accepted for publication April 26, 1996. Address for reprints: Francis G. Spinale, MD, PhD, Division of Cardiothoracic Surgery, Medical University of South Carolina, 171 Ashley Ave., Charleston, SC 29425.
Abstract
The majority of myocardial protective techniques performed in the United States incorporate hypothermic, hyperkalemic blood or crystalloid cardioplegia. Oxygenated blood cardioplegia has not been compared with oxygenated crystalloid cardioplegia in an isolated myocyte model of hypothermic, hyperkalemic cardioplegic arrest in which direct measurements of contractile function and myocyte swelling can be made. Accordingly, isolated myocyte contractile function and myocyte profile surface area were examined after hypothermic arrest with oxygenated crystalloid or blood cardioplegia. Methods: Isolated left ventricular pig myocytes were randomly assigned to undergo cardioplegic arrest for 2 hours at 4° C. Either oxygenated crystalloid or blood cardioplegia was used. After 2 hours, myocytes were reperfused with standard cell medium at 37° C and contractile function was examined. A control group of myocytes was maintained in cell medium at 37° C for 2 hours. Myocyte velocity of shortening (micrometers per second) was examined at baseline and afterß-adrenergic stimulation (isoproterenol, 25 nmol/L). Velocity of shortening declined equally from baseline control values (65 ± 2µm/sec) in the groups subjected to oxygenated crystalloid cardioplegia and blood cardioplegia (37 ± 2µm/sec and 42 ± 1µm/sec, respectively; p < 0.05). Results: Althoughß-adrenergic stimulation caused a significant increase in velocity of shortening in all myocyte groups, the increase was less pronounced in myocytes subjected to crystalloid cardioplegia (157 ± 6µm/sec) and blood cardioplegia (159 ± 6µm/sec) than in normothermic control myocytes (205 ± 7µm/sec; p < 0.05). Myocyte profile surface area, an index of cell volume, was measured in all myocyte groups. Myocyte surface area increased equally after cardioplegic arrest and rewarming in both cardioplegia groups (crystalloid 4119 ± 53µm2; blood 3924 ± 48µm2); surface areas in both cardioplegia groups were significantly greater than in the normothermic control group (3158 ± 39µm2, p < 0.05). Conclusion: Equivalent effects of oxygenated crystalloid and blood cardioplegia were observed with respect to myocyte contractile function, inotropic responsiveness, and intracellular volume regulatory processes. (J THORACCARDIOVASCSURG1996;112:1064-72)
This article has been cited by other articles:
![]() |
S. Mizutani, A. S. Al-Dadah, J. B. Bloch, S. M. Prasad, M. D. Diodato, R. B. Schuessler, R. J. Damiano Jr, and J. S. Lawton Hyperkalemic Cardioplegia-Induced Myocyte Swelling and Contractile Dysfunction: Prevention by Diazoxide Ann. Thorac. Surg., January 1, 2006; 81(1): 154 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mizutani, S. M. Prasad, A. D. Sellitto, R. B. Schuessler, R. J. Damiano Jr, and J. S. Lawton Myocyte Volume and Function in Response to Osmotic Stress: Observations in the Presence of an Adenosine Triphosphate-Sensitive Potassium Channel Opener Circulation, August 30, 2005; 112(9_suppl): I-219 - I-223. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, C. T. Ducko, E. M. Hoenicke, K. Reigle, and R. J. Damiano Jr Mechanisms responsible for cell volume regulation during hyperkalemic cardioplegic arrest Ann. Thorac. Surg., August 1, 2000; 70(2): 633 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Stephenson Jr, A. M. Jayawant, C. M. Baumgarten, and R. J. Damiano Jr Cardioplegia-induced cell swelling: prevention by normothermic infusion Ann. Thorac. Surg., May 1, 2000; 69(5): 1393 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Spinale Cellular and molecular therapeutic targets for treatment of contractile dysfunction after cardioplegic arrest Ann. Thorac. Surg., November 1, 1999; 68(5): 1934 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Danetz, H. F. Clemo, R. D. Davies, R. P. Embrey, R. J. Damiano Jr, and C. M. Baumgarten AGE-RELATED EFFECTS OF ST THOMAS’ HOSPITAL CARDIOPLEGIC SOLUTION ON ISOLATED CARDIOMYOCYTE CELL VOLUME J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 467 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Shaffer, C. M. Baumgarten, and R. J. Damiano Jr. Prevention of cellular edema directly caused by hypothermic cardioplegia: Studies in isolated human and rabbit atrial myocytes J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1189 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Clemo and C. M. Baumgarten Swelling-activated Gd3+-sensitive Cation Current and Cell Volume Regulation in Rabbit Ventricular Myocytes J. Gen. Physiol., September 1, 1997; 110(3): 297 - 312. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |